Arvinas, Inc. (ARVN) vs Capricor Therapeutics, Inc. (CAPR)

Arvinas, Inc. and Capricor Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and Capricor Therapeutics, Inc. are of similar size ($509.4M and $508.7M). Capricor Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Capricor Therapeutics, Inc. grew revenue faster over the last twelve months: −11.6% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs −1,019.7%). Across the 18 metrics below, Arvinas, Inc. leads on 10 and Capricor Therapeutics, Inc. on 8.